Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, et al
The marked WL achieved with tirzepatide in the SURPASS trials led to the phase 3 SURMOUNT programme, assessing tirzepatide as treatment for obesity [16]
Feb 22, 2026 Some people qualify for GLP-1 medications at a BMI of 27
I recommend Reducore to people who: Have diabetes Are obese Want milder metabolic support Are not candidates for GLP-1 medications Do not want injections Want to support blood sugar balance naturally Are focused on gut health and satiety Want muscle-supportive metabolic nutrition Want to save money Want sustained weight loss over time without rebound weight gain My clients with Metabolic Syndrome Have high tryglycerides Have high blood pressure in conjunction with obesity It may also make sense for: People transitioning off GLP-1 medications Individuals trying to support maintenance habits People wanting nutirtional support alongside lifestyle changes What are the downsides to GLP-1 injections
Most common GLP-1 side effects The most common side effects of Semaglutide (GLP-1) medications include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
There is some evidence that some of these ingredients can provide weight loss benefits
